138 related articles for article (PubMed ID: 8047822)
1. Prevention of duodenal ulcer relapse by long-term treatment with omeprazole.
Festen HP
Scand J Gastroenterol Suppl; 1994; 201():39-41. PubMed ID: 8047822
[TBL] [Abstract][Full Text] [Related]
2. Long term treatment with omeprazole 20 mg three days a week or 10 mg daily in the prevention of duodenal ulcer relapse.
Bianchi Porro G; Corinaldesi R; Lazzaroni M; Barbara L; Capurso L; Paoluzi P; Mangiameli A; Sabbatini F; Franceschi M; Bolling E
Aliment Pharmacol Ther; 1994 Oct; 8(5):541-8. PubMed ID: 7865647
[TBL] [Abstract][Full Text] [Related]
3. Omeprazole 20 mg three days a week and 10 mg daily in prevention of duodenal ulcer relapse. Double-blind comparative trial.
Lauritsen K; Andersen BN; Laursen LS; Hansen J; Havelund T; Eriksen J; Rehfeld JF; Kjaergaard J; Rask-Madsen J
Gastroenterology; 1991 Mar; 100(3):663-9. PubMed ID: 1993488
[TBL] [Abstract][Full Text] [Related]
4. Prevention of duodenal ulcer relapse with omeprazole 20 mg daily: a randomized double-blind, placebo-controlled study.
Goh KL; Boonyapisit S; Lai KH; Chang R; Kang JY; Lam SK
J Gastroenterol Hepatol; 1995; 10(1):92-7. PubMed ID: 7620115
[TBL] [Abstract][Full Text] [Related]
5. [Study on omeprazole 20 mg twice weekly in prevention of duodenal ulcer relapse].
Chen SP; Bei L; Wen SH
Zhonghua Nei Ke Za Zhi; 1993 Aug; 32(8):538-41. PubMed ID: 8269784
[TBL] [Abstract][Full Text] [Related]
6. Economic evaluation in gastrointestinal disease.
Jönsson B; Karlsson G
Scand J Gastroenterol Suppl; 1996; 220():44-51. PubMed ID: 8898435
[TBL] [Abstract][Full Text] [Related]
7. Clinical development programme for omeprazole.
Walan A
Digestion; 1990; 47 Suppl 1():54-8; discussion 76. PubMed ID: 2093016
[TBL] [Abstract][Full Text] [Related]
8. Effect of triple therapy or amoxycillin plus omeprazole or amoxycillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1-year follow-up period: a prospective, randomized, controlled study.
Saberi-Firoozi M; Massarrat S; Zare S; Fattahi M; Javan A; Etaati H; Dehbashi N
Am J Gastroenterol; 1995 Sep; 90(9):1419-23. PubMed ID: 7661161
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the cost of maintenance therapy (6 months) with 150 mg ranitidine vs 20 mg omeprazole vs 20 mg omeprazole every other day in duodenal ulcer].
Di Mario F; Grasso GA; Battaglia G; De Boni M; Vianello F; De Bona M; Pasquino M; Chiozzini G; Saggioro A
Minerva Gastroenterol Dietol; 1993 Jun; 39(2):83-7. PubMed ID: 8364105
[TBL] [Abstract][Full Text] [Related]
10. Eradication of Helicobacter pylori compared with long-term acid suppression in duodenal ulcer disease. A randomized trial with 2-year follow-up. The Danish Ulcer Study Group.
Bytzer P; Aalykke C; Rune S; Weywadt L; Gjørup T; Eriksen J; Bonnevie O; Bekker C; Kromann-Andersen H; Kjaergaard J; Rask-Madsen J; Vilien M; Hansen J; Justesen T; Vyberg M; Teglbjaerg PS
Scand J Gastroenterol; 2000 Oct; 35(10):1023-32. PubMed ID: 11099054
[TBL] [Abstract][Full Text] [Related]
11. Duodenal ulcer treated with omeprazole: healing and relapse rates. Does treatment duration influence subsequent remission?
Farup PG; Rosseland AR; Halvorsen L; Andersen OK; Bernklev T
Scand J Gastroenterol; 1989 Nov; 24(9):1107-12. PubMed ID: 2688070
[TBL] [Abstract][Full Text] [Related]
12. Ulcer recurrence following duodenal ulcer healing with omeprazole, ranitidine, or placebo: a double-blind, multicenter, 6-month study. The Omeprazole Duodenal Ulcer Study Group.
Graham DY; Colon-Pagan J; Morse RS; Johnson TL; Walsh JH; McCullough AJ; Marks JW; Sklar M; Stone RC; Cagliola AJ
Gastroenterology; 1992 Apr; 102(4 Pt 1):1289-94. PubMed ID: 1551535
[TBL] [Abstract][Full Text] [Related]
13. Short- and long-term omeprazole for the treatment and prevention of duodenal ulcer, and effect on Helicobacter pylori.
Marzio L; Biasco G; Cifani F; DeFanis C; Falcucci M; Ferrini G; Grossi L; Iannetti G; Larcinese G; Lattanzio R
Am J Gastroenterol; 1995 Dec; 90(12):2172-6. PubMed ID: 8540510
[TBL] [Abstract][Full Text] [Related]
14. [Long-term cyclic and periodic omeprazole in the prevention of recurrences of duodenal ulcer].
Bisi G; Dalla Libera M; Gullini S; Tartari V; Caravita L; Massari M; Cappellari L; Zibordi U; Matarese V
Recenti Prog Med; 1995 Apr; 86(4):137-42. PubMed ID: 7617955
[TBL] [Abstract][Full Text] [Related]
15. Antisecretory effects of three omeprazole regimens for maintenance treatment in duodenal ulcer.
Savarino V; Mela GS; Zentilin P; Cutela P; Mele MR; Perilli D; Vassallo A; Zambotti A; Mansi C; Celle G
Dig Dis Sci; 1994 Jul; 39(7):1473-82. PubMed ID: 8026259
[TBL] [Abstract][Full Text] [Related]
16. Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders.
Wilde MI; McTavish D
Drugs; 1994 Jul; 48(1):91-132. PubMed ID: 7525198
[TBL] [Abstract][Full Text] [Related]
17. Triple therapy for Helicobacter pylori eradication is more effective than long-term maintenance antisecretory treatment in the prevention of recurrence of duodenal ulcer: a prospective long-term follow-up study.
Wong BC; Lam SK; Lai KC; Hu WH; Ching CK; Ho J; Yuen ST; Chan CK; Lau GK; Lai CL
Aliment Pharmacol Ther; 1999 Mar; 13(3):303-9. PubMed ID: 10102962
[TBL] [Abstract][Full Text] [Related]
18. Omeprazole: a pharmacoeconomic evaluation of its use in duodenal ulcer and reflux oesophagitis.
Barradell LB; McTavish D
Pharmacoeconomics; 1993 Jun; 3(6):482-510. PubMed ID: 10146883
[TBL] [Abstract][Full Text] [Related]
19. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
Florent C
Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
[TBL] [Abstract][Full Text] [Related]
20. Emerging strategies for managing peptic ulcer disease.
Freston JW
Scand J Gastroenterol Suppl; 1994; 201():49-54. PubMed ID: 8047824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
